Ledger.Open graph →
SEC Form D · filed January 22, 2019

Lindy Biosciences, Inc

Offering
$1.6M
Sold
$548K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Research Triangle Park, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Karen Levert · Durham, NCExec · DirectorSreekar Gadde · Research Triangle Park, NCDirectorDeborah Bitterfield · Durham, NCExec · Director · PromoterKaren Levert · Durham, NCExec · DirectorSreekar Gadde · Research Triangle Park, NCDirectorDeborah Bitterfield · Durham, NCExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗